NEK7 inhibitor for neuroinflammation (Halia Therapeutics)

N/A

Report date: 2025/03/20 16:09:57
NME

Base Information

Drug NameNEK7 inhibitor for neuroinflammation (Halia Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Nek7 inhibitors
TargetsSerine/threonine-protein kinase Nek7
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHalia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHalia Therapeutics Inc
Inactive CompaniesN/A
Active Indications +[1]  N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A